Abstract. Maintenance of the chondrocyte phenotype is crucial for cartilage repair during tissue engineering. Intraflagellar transport protein 88 (IFT88) is an essential component of primary cilia, shuttling signals along the axoneme. The hypothesis of the present study was that IFT88 could exert an important role in icariin-regulated maintenance of the chondrocyte phenotype. To this end, the effects of icariin on proliferation and differentiation of the chondrogenic cell line, ATDC5, were explored. Icariin-treated ATDC5 cells and primary chondrocytes expressed IFT88. Icariin has been demonstrated to aid in the maintenance of the articular cartilage phenotype in a rat model of post-traumatic osteoarthritis (PTOA). Icariin promoted chondrocyte proliferation and expression of the chondrogenesis marker genes, COL II and SOX9, increased ciliary assembly, and upregulated IFT88 expression in a concentration-and time-dependent manner. Icariin-treated PTOA rats secreted more cartilage matrix compared with the controls. Knockdown of IFT88 expression with siRNA reduced extracellular signal-regulated kinase (ERK) phosphorylation, and icariin upregulated IFT88 expression by promoting ERK phosphorylation. Thus, IFT88 serves a major role in icariin-mediated maintenance of the chondrocyte phenotype, promoting ciliogenesis and IFT88 expression by increasing ERK phosphorylation. Icariin may therefore be useful for maintenance of the cartilage phenotype during tissue engineering.
Introduction
Articular cartilage injury can trigger joint pain and dysfunction. Cartilage exhibits a poor capacity for self-repair. Cartilage degeneration after trauma or during disease may readily trigger osteoarthritis (1) . Cartilage tissue engineering is considered to be a promising approach towards cartilage repair. Various scaffolds promoting cartilage generation may be utilized, and chondrocyte proliferation and differentiation can be guided by application of suitable biological stimuli. However, maintenance of the phenotype of regenerated cartilage, and long-term retention of normal function, remain challenging.
Icariin is a monomeric compound identified in extracts of Herba Epimedii; the protein exhibits a cardioprotective effect, may be used to treat osteoporosis, and has aphrodisiac qualities (2, 3) . Icariin promoted B-cell lymphoma 2 (Bcl-2) gene expression and suppressed Bax gene expression, thus inhibiting ventricular remodeling and myocardial cell apoptosis (4) . Icariin upregulated cyclic guanosine 3',5'-monophosphate (cGMP) levels and inhibited phosphodiesterase type 5, thus promoting nitric oxide (NO) release (a property of aphrodisiacs) (2) . In the context of osteoporosis, icariin promoted osteogenic differentiation of rat bone marrow stromal cells (BMSCs) by activating the phosphoinositide 3-kinase (PI3K)-AKT-endothelial NO synthase (eNOS)-NO-cGMP-protein kinase G (PKG) signaling axis, triggering rapid phosphorylation of c-Jun N-terminal kinase (JNK), p38 kinase, and extracellular signal-regulated kinase (ERK) (5, 6) . Li et al (7) demonstrated that an icariin-impregnated hydrogel scaffold efficiently promoted repair of supercritically sized osteochondral defects, and enhanced the integration of regenerated cartilage and subchondral bone in a rabbit model.
Primary cilia are non-motile microtubular organelles protruding from the surfaces of most eukaryotic cells. Cilia serve as 'antennae', detecting mechanical stress, and they engage in biochemical signal transduction from the extracellular environment (8) . Intraflagellar transport 88 (IFT88) is a key ciliary protein that shuttles cargos along the ciliary axoneme (9,10). In chondrocytes, primary cilia transmit mechanical stress and chemical signals (11) (12) (13) 
Materials and methods

Cells and reagents.
The progenitor chondrocytic cell line ATDC5 was purchased from the American Type Culture Collection (Manassas, VA, USA). Primary chondrocytes were obtained from the knee cartilage of 6 newborn (3 days old, 6-9 g) Sprague-Dawley (SD) rats of either sex (3 male and 3 female,). These SD rats were provided by the Experimental Animal Center (Tongji Hospital, Wuhan, China). All animals were maintained in the same housing conditions with free access to food and water (see below 'Animal experiments' section). Cells were cultured in Dulbecco's modified Eagle's medium/nutrient mixture F-12 (DMEM/F12) supplemented with 10% (v/v) fetal bovine serum (FBS) and 100 U/ml penicillin/streptomycin. Icariin was purchased from the Cayman Chemical Company (Ann Arbor, MI, USA). The ERK inhibitor, PD0325901, was obtained from Selleckchem (Houston, TX, USA).
Cell viability assay. The effect of icariin on ATDC5 cell proliferation was evaluated with the aid of a CCK-8 kit (Wuhan Boster Biological Technology, Ltd., Wuhan, China). Cells (2,000/well) were seeded into 96-well plates and cultured in 100 µl DMEM/F12 with 10% (v/v) FBS medium containing different concentrations of icariin (0.001-10 µmol/l). After 48 h, 10 µl amounts of CCK-8 solution were added to the wells, followed by incubation at 37˚C for 90 min. Absorbance at 450 nm was measured using a microplate reader.
Histochemical and immunohistochemical assays.
Chondrocytes (obtained from the aforementioned newborn rats) and the knee joints of 8-week old SD rats described below, were subjected to histochemical staining. Cells were fixed in 4% (v/v) paraformaldehyde for 15 min, and subsequently stained with 0.5% (v/v) toluidine blue. The knee joints were fixed in 4% (v/v) paraformaldehyde for 2 days, decalcified for 4 weeks in 10% (w/v) EDTA, embedded in paraffin, and stained with Safranin O-Fast Green and toluidine blue, following standard protocols. All immunohistochemical techniques followed were as described previously (16 siRNA transfection. ATDC5 progenitor chondrocytic cells were transfected with 100 nM siRNA targeting IFT88 or a negative control siRNA (Guangzhou RiboBio Co., Ltd., Guangzhou, China), using a standard protocol. Knockdown efficiency was evaluated by western blotting.
Quantitative polymerase chain reaction (qPCR).
Expression levels of genes affecting the chondrocyte phenotype (COL-II, SOX9, and IFT88) were measured by qPCR. Total RNA was extracted with TRIzol and cDNAs were synthesized from 2 µg amounts of total RNA using a Toyobo cDNA synthesis kit (Toyobo, Co., Ltd., Osaka, Japan), according to the manufacturer's protocol. Each PCR tube contained 1 µl cDNA, 1 µl primers, 10 µl SYBR-Green DNA polymerase (Toyobo, Co., Ltd.), and 8 µl RNAse-free water. The primers sequences are listed in Table I .
Animal experiments. The present study was approved by the Ethics Committee of Tongji Hospital (Wuhan, China). A total of 24 male SD rats (8 weeks old, 180-220 g) were divided into four groups (control, treadmill, icariin, and icariin + treadmill). Animals were purchased from the Experimental Animal Center, Tongji Hospital, (Wuhan, China). All these rats were maintained with free access to food and water, at a constant room temperature of 23±1˚C with a 12 h light/dark cycle, 50-70% humidity and 0.03% CO 2 . Full-thickness cartilage defects were created, and early treadmill exercise was used to accelerate the development of post-traumatic osteoarthritis (PTOA). All rats underwent 1 week of treadmill training prior to surgery. Full-thickness cartilage defects were created by drilling a 1-mm-diameter hole through the middle of the femoral trochlea of the right knee, as described in a previous study (19) . Rats in the treadmill and icariin + treadmill groups commenced running exercises (15 m/min, 30 min/day) 1 week after surgery (19) , and were gavage-fed with icariin (25 mg/kg) or saline daily (20) . After 6 weeks, the rats were sacrificed and knee samples were subjected to histomorphological and immunohistochemical assessment.
Statistical analysis. All data are reported as the mean ± standard deviation, and means with 95% confidence intervals were calculated. Student's t-test or one-way analysis of variance was used to assess the significance of between-group differences. P<0.05 was considered to indicate a statistically significant difference.
Results
Icariin affects the proliferation and differentiation of ATDC5 chondrocytic cells. Icariin at different concentrations, added to growing cells, promoted ATDC5 proliferation in a concentration-dependent manner, peaking at 1 µmol/l (Fig. 1A) . Furthermore, icariin promoted the expression of the chondrocyte phenotype-associated genes, COL-II and SOX9, in a concentration-dependent manner, peaking at 10 µmol/l (Fig. 1B) . Following stimulation with 10 µmol/l icariin for 3 days, toluidine blue staining confirmed that icariin significantly promoted secretion of cartilage extracellular matrix (ECM) (Fig. 1C) .
Icariin promotes ciliary assembly in, and IFT88 expression by, ATDC5 cells.
The primary cilia regulate numerous cellular activities, particularly the balance between proliferation and differentiation (21, 22) . ATDC5 cells treated with 10 µmol/l icariin were analysed in terms of primary cilia production ( Fig. 2A and B) . Icariin-treated cells expressed a higher percentage of primary cilia (34.06±10.06% of cells) compared with the control group (27.91±9.95%). The average ciliary length of icariin-treated cells (3.34±1.34 µm) was slightly greater compared with that of the control cells (3.07±0.74 µm). IFT88 was expressed at both the gene and the protein level. RT-qPCR revealed that icariin enhanced the expression of mRNA encoding IFT88 in a concentration-dependent manner, peaking at 10 µmol/l (Fig. 2C) . Icariin promoted the protein expression of IFT88 in a concentration-and a time-dependent manner, peaking at 1 or 10 µmol/l. When exposed to 10 µmol/l icariin for different times, the protein expression of IFT88 peaked at 24 h (Fig. 2D) .
Icariin facilitates ciliary assembly in primary chondrocytes and assists in maintenance of an appropriate phenotype.
Primary chondrocytes were treated with icariin (10 µmol/l) for 24 h, and the levels of primary cilia and IFT88 were measured. IFT88 protein was detected in the cytoplasm, although it was principally centralized along the axonemes of primary cilia (Fig. 3A) . Icariin-treated primary chondrocytes exhibited enhanced ciliary assembly (38.48±10.36%) compared with that of the control cells (29.54±8.24%), and a slight increase in ciliary length was revealed (from 2.48±0.85 to 2.65±0.63 µm; Fig. 3B ). Toluidine blue staining confirmed that icariin-treated primary chondrocytes secreted more cartilage matrix and expressed higher levels of the COL-II and SOX9 genes than did the control cells (Fig. 3C and D) .
Icariin attenuates cartilage degeneration in the PTOA rat model. Toluidine blue and Safranin O-Fast Green staining revealed that the treadmill and treadmill + icariin groups exhibited reductions in cartilage thickness in weight-bearing areas, whereas the treadmill group lost more of the superficial cartilage proteoglycans than did the treadmill + icariin group. Icariin-treated and control rats had thicker cartilages that were rich in proteoglycans (Fig. 4A) . Subsequently, the expression of aggrecan (a major component of the cartilage ECM that allows cartilage to resist compression) was explored (23). Aggrecan was clearly expressed in the icariin-treated group, but the treadmill group exhibited reduced expression in the upper and middle cartilage layers; addition of icariin partly reversed this decline (Fig. 4A) . When PTOA severity was assessed by the O'Driscoll system (19) , the scores of the control (12.833±1.169), icariin (13.667±1.211), and treadmill + icariin (6.833±1.472) groups were all significantly higher compared that of the treadmill group (5.167±0.983) (Fig. 4B) . Therefore, icariin was shown to improve the histological cartilage phenotype.
ERK phosphorylation is involved in icariin-mediated IFT88
expression. siRNA was used to knock down IFT88 gene expression, and this revealed that icariin rescued the reductions in COL-II and SOX9 expression levels induced by siRNA (Fig. 5A) . siRNA downregulated the expression of endogenous IFT88 and phosphorylated ERK (Fig. 5B) . Icariin (10 µmol/l) promoted IFT88 expression and ERK phosphorylation compared with the levels noted in the presence of IFT88 siRNA (Fig. 5C) . Inhibition of ERK phosphorylation by PD0325901 clearly reduced IFT88 expression; icariin did not rescue this decline (Fig. 5D) . Therefore, ERK phosphorylation may be involved in icariin-mediated IFT88 expression during maintenance of the chondrocyte phenotype.
Discussion
Maintenance of the cartilage phenotype is a major concern during cartilage tissue engineering. Although various biological materials and recombinant cytokines may be of assistance, these materials degrade rapidly, exhibit unpredictable side-effects, and are very costly (24) (25) (26) . In the present study, a Herba Epimedii extract, icariin, was shown to aid in maintenance of the cartilage phenotype, and the IFT88 protein of primary cilia served an important role in this context. Icariin exerts multiple functions. Li et al (7) demonstrated that, in animal models, icariin-impregnated hydrogel scaffolds efficiently promoted the repair of defects in superficial cartilage and osteochondral regions (7). Zhang et al (27) showed that icariin promoted chondrocyte clustering and ECM secretion (27) . In the present study, icariin was shown to promote cellular proliferation, and expression of the cartilage phenotype genes, COL-II and SOX9, in progenitor chondrocytic cells and primary chondrocytes was enhanced. These findings suggested that icariin may be valuable in cartilage tissue engineering. However, the mechanism by which icariin promotes cartilage repair has yet to be fully elucidated. IFT88, an intraflagellar transport protein, carries cargos into or out of primary cilia (9) . This protein has been shown to be very important in the development of cartilage (10, 28) . IFT88 affects actin organisation within chondrocytes, and also the biomechanical properties of cartilage (28) . IFT88 mutations render cartilage 'osteoarthritis-like', with reduction of the compressive modulus (29) . IFT88 fulfils a major role in the columnar organisation of growth plate cartilage (15) . In the present study, IFT88 was shown to be widely distributed in the cytoplasm, although it was principally concentrated along the ciliary axoneme. Icariin promoted ciliary assembly, but did not affect ciliary length. Icariin upregulated IFT88 expression at both the gene and the protein level, promoted ECM secretion, and increased the expression of COL-II and SOX9. Therefore, icariin enhanced maintenance of the cartilage phenotype and IFT88 exerted an important role in icariin-mediated ECM secretion. IFT88 knockdown suppressed ERK phosphorylation, and icariin partially rescued this reduction. Thus, there may be feedback between the IFT88 expression level and ERK phosphorylation in operation, and icariin contributes positively to such regulation. It was therefore confirmed that icariin increased ciliary assembly, enhanced IFT88 expression, promoted ciliary transportation, stimulated ERK phosphorylation, and induced SOX9 and COL-II gene expression to promote cartilage matrix secretion. Primary cilia and the IFT88 protein may serve important roles during cartilage P<0.01 compared with the control group). ERK, extracellular signal-regulated kinase; IFT88, intraflagellar transport protein 88; Ica, icariin; PD, PD0325901, Con, control; T-ERK, total ERK; P-ERK, phosphorylated ERK. development. However, the gene expression profile and the signaling systems involved require further study.
In conclusion, the present study explored the role exerted by the ciliary protein IFT88 in icariin-mediated maintenance of cartilage phenotype in progenitor cells and in primary chondrocytes. Icariin promoted ciliary assembly, enhanced intraflagellar transportation, induced ERK phosphorylation, and stimulated cartilage matrix secretion. Icariin thus aids in the maintenance of cartilage phenotype, and the present study has provided the theoretical basis for the use of icariin in cartilage tissue engineering.
